| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |